HYQVIA is indicated for the treatment of primary immunodeficiency (PI) in adults. HYQVIA is for subcutaneous use only. Safety and efficacy of chronic use of Recombinant Human Hyaluronidase in HYQVIA have not been established in conditions other than PI.

Administration training

Instructional videos. Helpful materials.

More time between infusions for what matters.1

Leverage these resources to help patients understand the HYQVIA administration process.

See Real Patient Experiences
with HyQvia Infusion

Mary's Infusion Experience

Michael's Infusion Experience

How to infuse HYQVIA with a peristaltic infusion pump

HYQVIA Administration guide: peristaltic infusion pump

How to infuse HYQVIA with a peristaltic infusion pump brochure

Download now
HYQVIA Administration guide: syringe driver pump

How to infuse HYQVIA with a syringe driver pump brochure

Download now
Reference:
  1. HYQVIA [prescribing information]. Lexington, MA: Baxalta US Inc.